SEVERE HAEMOPHILIA A
Clinical trials for SEVERE HAEMOPHILIA A explained in plain language.
Never miss a new study
Get alerted when new SEVERE HAEMOPHILIA A trials appear
Sign up with your email to follow new studies for SEVERE HAEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New clotting factor offers continued bleeding control for hemophilia a patients
Disease control Recruiting nowThis study gives people with moderate or severe hemophilia A who finished a previous trial continued access to the drug efanesoctocog alfa. The drug is a lab-made clotting factor that helps prevent bleeding episodes. Researchers will monitor safety and how well it controls bleedi…
Matched conditions: SEVERE HAEMOPHILIA A
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Hemophilia a study observes how new patients respond to factor VIII in daily practice
Knowledge-focused Recruiting nowThis study is observing how well three Factor VIII concentrates (Nuwiq, Octanate, Wilate) work in real-world settings for people with severe hemophilia A who have had little or no prior treatment. Researchers will track bleeding rates and side effects in about 200 participants of…
Matched conditions: SEVERE HAEMOPHILIA A
Sponsor: Octapharma • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC